Hill, Andrew M.; Gebo, Kelly; Hemmett, Lindsay; … - In: PharmacoEconomics 28 (2010) S1, pp. 169-181
Background: Given the association between CD4 cell counts and HIV-related morbidity/mortality, new antiretroviral therapies could potentially lower the direct costs of HIV care by raising CD4 cell counts. Objectives: To predict the effects of the ritonavir-boosted, HIV protease inhibitor (PI)...